Statewide

Michigan Department of Health and Human Services

Name: Michigan Department of Health and Human Services EMS protocol doses
Creator: ProtoQuiz
License: https://protoquiz.com/census/data-license/

Under review128 dose entries31 drugs37 documentsMIeffective 2026-02-2597% machine-parsed of 128

An undated version is under review. The figures below are from the current listed document.

Drugs and doses31

A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Cefazolin, Ceftriaxone8

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	0.1 mg/kg (max 6 mg)	IV	not captured	standing	pages 28, 29
Narrow-complex tachycardia	peds	0.1 mg/kg	IV	not captured	standing	pages 28, 29, 211, 213

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	2.5 mg	NEB	not captured	standing	pages 82, 83
Anaphylaxis	peds	2.5 mg	NEB	not captured	standing	pages 82, 83
Crush injury	adult	2.5 mg	NEB	not captured	standing	page 131
Crush injury	peds	2.5 mg	NEB	not captured	standing	page 131
Other	adult	2.5 mg	NEB	not captured	standing	page 90
Other	adult	2.5 mg	NEB	not captured	standing	page 184
Respiratory distress	adult	2.5 mg	NEB	not captured	standing	pages 190, 191
Respiratory distress	peds	2.5 mg	NEB	not captured	standing	pages 190, 191

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	300 mg	IV/IO	not captured	standing	pages 24, 25, 165
Cardiac arrest	peds	5 mg/kg	IV/IO	not captured	standing	pages 24, 25, 165
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	page 28

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	325 mg	PO	not captured	standing	page 97

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV/IO	not captured	standing	pages 87, 179
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 87, 179
Nerve agent exposure	adult	2 mg	IV/IM	not captured	standing	pages 152, 153
Nerve agent exposure	peds	0.05 mg/kg	IV/IM	not captured	standing	pages 152, 153
Other	adult	2 mg	IM	not captured	standing	page 152

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 25, 132, 165, 166
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	pages 25, 132, 165, 166

Cefazolin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV	not captured	standing	page 203
Other	adult	2 g	not captured	not captured	standing	page 203
Other	peds	30 mg/kg	IV	not captured	standing	page 203
Other	peds	30 mg/kg	not captured	not captured	standing	page 203

Ceftriaxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV	not captured	standing	page 203
Other	adult	2 g	not captured	not captured	standing	page 203
Other	peds	50 mg/kg	IV	not captured	standing	page 203
Other	peds	50 mg/kg	not captured	not captured	standing	page 203

D–F Dextrose, Diazepam, Diphenhydramine, Epinephrine, Fentanyl5

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV	not captured	standing	pages 12, 16, 19, 21
Other	peds	10 g	IV/IO	not captured	standing	pages 16, 19
Other	peds	12.5 g	IV/IO	not captured	standing	pages 16, 19
Other	peds	15 g	IV/IO	not captured	standing	pages 16, 19
Other	peds	4.25 g	IV/IO	not captured	standing	pages 16, 19
Other	peds	5 mL/kg	IV/IO	not captured	standing	pages 17, 21
Other	peds	5 g	IV/IO	not captured	standing	pages 16, 19
Other	peds	6.25 g	IV/IO	not captured	standing	pages 16, 19
Other	peds	8 g	IV/IO	not captured	standing	pages 16, 19
Seizure	adult	25 g	IV	not captured	standing	pages 14, 19, 21

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	10 mg	IM/IN	not captured	standing	page 152
Nerve agent exposure	peds	10 mg	IM/IN	not captured	standing	page 152

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	50 mg	IV/IO/IM	not captured	standing	page 83
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 83
Nausea / vomiting	adult	12.5–25 mg	IV/IM	not captured	standing	page 2
Nausea / vomiting	peds	1 mg/kg	IV/IM	not captured	standing	page 2
Other	peds	1 mg/kg	IV	not captured	standing	page 2

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 81, 82
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 81, 82
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 24, 165
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 24, 165
Hypotension / shock	adult	10–20 mcg	IV/IO	not captured	standing	pages 83, 200, 201
Other	adult	0.3 mg	IM	not captured	standing	page 82
Other	peds	0.15 mg	IM	not captured	standing	page 82
Respiratory distress	adult	0.3 mg	IM	not captured	standing	pages 174, 175, 191

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.5 mcg/kg	IV/IO/IN	not captured	standing	page 98
ACS / chest pain	adult	1 mcg/kg	IV/IO/IN	not captured	standing	page 98

G–L Glucagon, Hydrocortisone, Hydroxocobalamin, Ipratropium, Ketamine, Lidocaine6

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1 mg	IM	not captured	standing	pages 12, 17
Hypoglycemia	adult	3 mg	IN	not captured	standing	pages 12, 17
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	pages 12, 17
Other	peds	1 mg	IM	not captured	standing	pages 17, 20
Seizure	adult	1 mg	IM	not captured	standing	pages 14, 20
Seizure	adult	3 mg	IN	not captured	standing	pages 14, 20
Seizure	peds	0.5 mg	IM	not captured	standing	pages 14, 20
Seizure	peds	3 mg	IN	not captured	standing	pages 14, 20

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IM	not captured	standing	page 69
Adrenal crisis	peds	1–2 mg/kg	IV/IM	not captured	standing	page 69

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV/IO	not captured	standing	pages 116, 117
Cyanide poisoning	peds	70 mg/kg	IV/IO	not captured	standing	pages 116, 117

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	500 mcg	NEB	not captured	standing	pages 82, 83
Other	adult	500 mcg	NEB	not captured	standing	page 184
Respiratory distress	adult	500 mcg	NEB	not captured	standing	page 191
Respiratory distress	peds	500 mcg	NEB	not captured	standing	page 191

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	4 mg/kg	IM	not captured	standing	page 139

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1 mg/kg	IV/IO	not captured	standing	pages 24, 25, 165
Other	adult	1 mg/kg	IV/IO	not captured	standing	pages 24, 25, 165
Narrow-complex tachycardia	adult	1 mg/kg	IV/IO	not captured	standing	pages 28, 212, 213
Narrow-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	pages 28, 212, 213
Wide-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	page 28

M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Naloxone, Nitroglycerin, Ondansetron6

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV	not captured	standing	page 192
Asthma / bronchospasm	peds	2 g	IV	not captured	standing	page 192
Eclampsia / pre-eclampsia	adult	4 g	IV/IO	not captured	standing	pages 14, 108
Other	adult	2 g	IV/IO	not captured	standing	page 25
Other	adult	4 g	IV/IO	not captured	standing	pages 14, 108
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	page 25

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	125 mg	IV/IO/IM	not captured	standing	page 69
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 69
Anaphylaxis	adult	125 mg	IV/IO/IM	not captured	standing	page 84
Anaphylaxis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 84
Respiratory distress	adult	125 mg	IV/IO/IM	not captured	standing	page 192
Respiratory distress	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 192

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	10 mg	IM	not captured	standing	page 139
Nerve agent exposure	adult	10 mg	IM/IN	not captured	standing	page 152
Nerve agent exposure	peds	0.1 mg/kg	IM/IN	not captured	standing	page 152
Other	adult	0.1 mg/kg	IM/IN	not captured	standing	page 47
Other	peds	0.1 mg/kg	IM/IN	not captured	standing	page 47
Seizure	adult	10 mg	IM	not captured	standing	pages 14, 19
Seizure	adult	5 mg	IV/IO	not captured	standing	pages 14, 19
Seizure	adult	5 mg	IV/IO/IM/IN	not captured	standing	pages 15, 20
Seizure	peds	0.1 mg/kg	IM	not captured	standing	pages 14, 19
Seizure	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	pages 15, 20

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	2 mg	IN	not captured	standing	pages 156, 157
Opioid overdose	adult	2 mg	IV/IM	not captured	standing	page 157
Opioid overdose	peds	0.1 mg/kg	IV/IM	not captured	standing	page 157
Other	adult	2 mL	IN	not captured	standing	page 156
Other	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 157, 17
Other	peds	0.5 mL	IN	not captured	standing	page 156
Other	peds	1 mL	IN	not captured	standing	page 156
Other	peds	1.5 mL	IN	not captured	standing	page 156
Other	peds	2 mL	IN	not captured	standing	page 156

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 97, 98, 184
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 184
Other	adult	0.4 mg	SL	not captured	standing	page 184

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	ODT	not captured	standing	page 1
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	pages 1, 2
Nausea / vomiting	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 1, 2
Nausea / vomiting	peds	4 mg	ODT	not captured	standing	page 1

P–R Pralidoxime, Prednisone, Racemic Epinephrine3

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IV/IM	not captured	standing	pages 148, 152

Prednisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	50 mg	PO	not captured	standing	page 69
Adrenal crisis	peds	50 mg	PO	not captured	standing	page 69
Anaphylaxis	adult	50 mg	PO	not captured	standing	page 83
Anaphylaxis	peds	50 mg	PO	not captured	standing	page 83
Respiratory distress	adult	50 mg	PO	not captured	standing	page 191
Respiratory distress	peds	50 mg	PO	not captured	standing	page 191

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Stridor	peds	0.5 mL	NEB	not captured	standing	page 176

S–Z Sodium Bicarbonate, Tetracaine, Tranexamic Acid3

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 mEq/kg	IV/IO	not captured	standing	pages 25, 132, 166
Tricyclic overdose	adult	1 mEq/kg	IV/IO	not captured	standing	pages 25, 180

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–2 drop	OPH	not captured	standing	page 181

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	page 137

Cite this

Michigan Department of Health and Human Services, United States EMS Protocol Census. 128 dose entries, effective 2026-02-25.

https://protoquiz.com/census/agencies/michigan-department-of-health-and-human-services-mdhhs/

Outdated or wrong? Fix or remove it All Michigan agencies Methodology Data license Study these protocols in the app

The census is free and not for sale. Only public agencies are named.